Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report

Cardiovascular Center, OLV Hospital, Aalst, Belgium.

OBJECTIVES. The objectives of this study were to present data on eight patients with recurrent episodes of aborted sudden death unexplainable by currently known diseases whose common clinical and electrocardiographic (ECG) features define them as having a distinct syndrome different from idiopathic ventricular fibrillation. BACKGROUND. Among patients with ventricular arrhythmias who have no structural heart disease, several subgroups have been defined. The present patients constitute an additional subgroup with these findings. METHODS. The study group consisted of eight patients, six male and two female, with recurrent episodes of aborted sudden death. Clinical and laboratory data and results of electrocardiography, electrophysiology, echocardiography, angiography, histologic study and exercise testing were available in most cases. RESULTS. The ECG during sinus rhythm showed right bundle branch block, normal QT interval and persistent ST segment elevation in precordial leads V1 to V2-V3 not explainable by electrolyte disturbances, ischemia or structural heart disease. No histologic abnormalities were found in the four patients in whom ventricular biopsies were performed. The arrhythmia leading to (aborted) sudden death was a rapid polymorphic ventricular tachycardia initiating after a short coupled ventricular extrasystole. A similar arrhythmia was initiated by two to three ventricular extrastimuli in four of the seven patients studied by programmed electrical stimulation. Four patients had a prolonged HV interval during sinus rhythm. One patient receiving amiodarone died suddenly during implantation of a demand ventricular pacemaker. The arrhythmia of two patients was controlled with a beta-adrenergic blocking agent. Four patients received an implantable defibrillator that was subsequently used by one of them, and all four are alive. The remaining patient received a demand ventricular pacemaker and his arrhythmia is controlled with amiodarone and diphenylhydantoin. CONCLUSIONS. Common clinical and ECG features define a distinct syndrome in this group of patients. Its causes remain unknown.

This article has been cited by other articles:

				H. M. Barajas-Martinez, D. Hu, J. M. Cordeiro, Y. Wu, R. J. Kovacs, H. Meltser, H. Kui, B. Elena, R. Brugada, C. Antzelevitch, et al. Lidocaine-Induced Brugada Syndrome Phenotype Linked to a Novel Double Mutation in the Cardiac Sodium Channel Circ. Res., August 15, 2008; 103(4): 396 - 404. [Abstract] [Full Text] [PDF]

				E. Delpon, J. M. Cordeiro, L. Nunez, P. E. B. Thomsen, A. Guerchicoff, G. D. Pollevick, Y. Wu, J. K. Kanters, C. T. Larsen, E. Burashnikov, et al. Functional Effects of KCNE3 Mutation and Its Role in the Development of Brugada Syndrome Circ Arrhythmia Electrophysiol, August 1, 2008; 1(3): 209 - 218. [Abstract] [Full Text] [PDF]

				M. A. Babaee Bigi, A. Aslani, and A. Aslani Significance of cardiac autonomic neuropathy in risk stratification of Brugada syndrome Europace, July 1, 2008; 10(7): 821 - 824. [Abstract] [Full Text] [PDF]

				D. Erkapic, T. Neumann, J. Schmitt, J. Sperzel, A. Berkowitsch, M. Kuniss, C. W. Hamm, and H.-F. Pitschner Electrical storm in a patient with arrhythmogenic right ventricular cardiomyopathy and SCN5A mutation Europace, July 1, 2008; 10(7): 884 - 887. [Abstract] [Full Text] [PDF]

				T. Wichter What role for autonomic dysfunction in Brugada Syndrome? Pathophysiological and prognostic implications Europace, July 1, 2008; 10(7): 782 - 783. [Full Text] [PDF]

				M. Bebarova, T. O'Hara, J. L. M. C. Geelen, R. J. Jongbloed, C. Timmermans, Y. H. Arens, L.-M. Rodriguez, Y. Rudy, and P. G. A. Volders Subepicardial phase 0 block and discontinuous transmural conduction underlie right precordial ST-segment elevation by a SCN5A loss-of-function mutation Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H48 - H58. [Abstract] [Full Text] [PDF]

				A. E. Epstein, J. P. DiMarco, K. A. Ellenbogen, N.A. M. Estes III, R. A. Freedman, L. S. Gettes, A. M. Gillinov, G. Gregoratos, S. C. Hammill, D. L. Hayes, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons J. Am. Coll. Cardiol., May 27, 2008; 51(21): e1 - e62. [Full Text] [PDF]

				A. E. Epstein, J. P. DiMarco, K. A. Ellenbogen, N.A. M. Estes III, R. A. Freedman, L. S. Gettes, A. M. Gillinov, G. Gregoratos, S. C. Hammill, D. L. Hayes, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons Circulation, May 27, 2008; 117(21): e350 - e408. [Full Text] [PDF]

				Y. Aizawa, M. Chinushi, M. Tagawa, H. Furushima, S. Okada, K. Iijima, D. Izumi, H. Watanabe, and S. Komura A Post-QRS Potential in Brugada Syndrome: Its Relation to Electrocardiographic Pattern and Possible Genesis J. Am. Coll. Cardiol., April 29, 2008; 51(17): 1720 - 1721. [Full Text] [PDF]

				M. J. Junttila, M. Gonzalez, E. Lizotte, B. Benito, K. Vernooy, A. Sarkozy, H. V. Huikuri, P. Brugada, J. Brugada, and R. Brugada Induced Brugada-Type Electrocardiogram, a Sign for Imminent Malignant Arrhythmias Circulation, April 8, 2008; 117(14): 1890 - 1893. [Full Text] [PDF]

				J. Francis and C. Antzelevitch Atrial Fibrillation and Brugada Syndrome J. Am. Coll. Cardiol., March 25, 2008; 51(12): 1149 - 1153. [Abstract] [Full Text] [PDF]

				S. Nagase, K. F. Kusano, H. Morita, N. Nishii, K. Banba, A. Watanabe, S. Hiramatsu, K. Nakamura, S. Sakuragi, and T. Ohe Longer Repolarization in the Epicardium at the Right Ventricular Outflow Tract Causes Type 1 Electrocardiogram in Patients With Brugada Syndrome J. Am. Coll. Cardiol., March 25, 2008; 51(12): 1154 - 1161. [Abstract] [Full Text] [PDF]

				M. Hayashi, S. Takatsuki, P. Maison-Blanche, A. Messali, A. Haggui, P. Milliez, A. Leenhardt, and F. Extramiana Ventricular Repolarization Restitution Properties in Patients Exhibiting Type 1 Brugada Electrocardiogram With and Without Inducible Ventricular Fibrillation J. Am. Coll. Cardiol., March 25, 2008; 51(12): 1162 - 1168. [Abstract] [Full Text] [PDF]

				K. F. Kusano, M. Taniyama, K. Nakamura, D. Miura, K. Banba, S. Nagase, H. Morita, N. Nishii, A. Watanabe, T. Tada, et al. Atrial Fibrillation in Patients With Brugada Syndrome: Relationships of Gene Mutation, Electrophysiology, and Clinical Backgrounds J. Am. Coll. Cardiol., March 25, 2008; 51(12): 1169 - 1175. [Abstract] [Full Text] [PDF]

				P.-S. Chen and S. G. Priori The Brugada Syndrome J. Am. Coll. Cardiol., March 25, 2008; 51(12): 1176 - 1180. [Full Text] [PDF]

				S Chutani, N Imran, B Grubb, and Y Kanjwal Propafenone-induced Brugada-like ECG changes mistaken as acute myocardial infarction Emerg. Med. J., February 1, 2008; 25(2): 117 - 118. [Abstract] [Full Text] [PDF]

				T. Ueyama, A. Shimizu, M. Esato, Y. Yoshiga, A. Sawa, S. Suzuki, N. Sugi, and M. Matsuzaki Pilsicainide-induced Brugada-type ECG and ventricular arrhythmias originating from the left posterior fascicle in a case with Brugada syndrome associated with idiopathic left ventricular tachycardia Europace, January 1, 2008; 10(1): 86 - 90. [Abstract] [Full Text] [PDF]

				I. Six, J.-S. Hermida, H. Huang, L. Gouas, V. Fressart, N. Benammar, B. Hainque, I. Denjoy, M. Chahine, and P. Guicheney The occurrence of Brugada syndrome and isolated cardiac conductive disease in the same family could be due to a single SCN5A mutation or to the accidental association of both diseases Europace, January 1, 2008; 10(1): 79 - 85. [Abstract] [Full Text] [PDF]

				S. Kalra, S. B. Iskandar, S. Duggal, and R. D. Smalligan Fever-Induced ST-Segment Elevation with a Brugada Syndrome-Type Electrocardiogram Ann Intern Med, January 1, 2008; 148(1): 82 - 84. [Full Text] [PDF]

				R. Sutton, J. D. Fisher, C. Linde, and D. G. Benditt History of electrical therapy for the heart Eur. Heart J. Suppl., December 1, 2007; 9(suppl_I): I3 - I10. [Abstract] [Full Text] [PDF]

				A. Sarkozy, P. Brugada, L. Mont, and J. Brugada Optimizing the clinical use of implantable defibrillators in patients with Brugada syndrome Eur. Heart J. Suppl., December 1, 2007; 9(suppl_I): I74 - I80. [Abstract] [Full Text] [PDF]

				H. V.M. van Rijen and J. M.T. de Bakker Penetrance of monogenetic cardiac conduction diseases. A matter of conduction reserve? Cardiovasc Res, December 1, 2007; 76(3): 379 - 380. [Full Text] [PDF]

				S. E. Lehnart, M. J. Ackerman, D. W. Benson Jr, R. Brugada, C. E. Clancy, J. K. Donahue, A. L. George Jr, A. O. Grant, S. C. Groft, C. T. January, et al. Inherited Arrhythmias: A National Heart, Lung, and Blood Institute and Office of Rare Diseases Workshop Consensus Report About the Diagnosis, Phenotyping, Molecular Mechanisms, and Therapeutic Approaches for Primary Cardiomyopathies of Gene Mutations Affecting Ion Channel Function Circulation, November 13, 2007; 116(20): 2325 - 2345. [Abstract] [Full Text] [PDF]

				B. London, M. Michalec, H. Mehdi, X. Zhu, L. Kerchner, S. Sanyal, P. C. Viswanathan, A. E. Pfahnl, L. L. Shang, M. Madhusudanan, et al. Mutation in Glycerol-3-Phosphate Dehydrogenase 1-Like Gene (GPD1-L) Decreases Cardiac Na+ Current and Causes Inherited Arrhythmias Circulation, November 13, 2007; 116(20): 2260 - 2268. [Abstract] [Full Text] [PDF]

				M. A. Babai Bigi, A. Aslani, and S. Shahrzad Clinical predictors of atrial fibrillation in Brugada syndrome Europace, October 1, 2007; 9(10): 947 - 950. [Abstract] [Full Text] [PDF]

				H. Furushima, M. Chinushi, K. Okamura, K. Iijima, S. Komura, Y. Tanabe, S. Okada, D. Izumi, and Y. Aizawa Comparison of conduction delay in the right ventricular outflow tract between Brugada syndrome and right ventricular cardiomyopathy: investigation of signal average ECG in the precordial leads Europace, October 1, 2007; 9(10): 951 - 956. [Abstract] [Full Text] [PDF]

				C. Antzelevitch Role of spatial dispersion of repolarization in inherited and acquired sudden cardiac death syndromes Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2024 - H2038. [Abstract] [Full Text] [PDF]

				M. Paul, J. Gerss, E. Schulze-Bahr, T. Wichter, C. Vahlhaus, A. A.M. Wilde, G. Breithardt, and L. Eckardt Role of programmed ventricular stimulation in patients with Brugada syndrome: a meta-analysis of worldwide published data Eur. Heart J., September 1, 2007; 28(17): 2126 - 2133. [Abstract] [Full Text] [PDF]

				N. van Dijk, M. C. Boer, T. De Santo, N. Grovale, A. J.J. Aerts, L. Boersma, and W. Wieling Daily, weekly, monthly, and seasonal patterns in the occurrence of vasovagal syncope in an older population Europace, September 1, 2007; 9(9): 823 - 828. [Abstract] [Full Text] [PDF]

				E. A. Stephenson and C. I. Berul Electrophysiological Interventions for Inherited Arrhythmia Syndromes Circulation, August 28, 2007; 116(9): 1062 - 1080. [Full Text] [PDF]

				N. H. Robin, P. B. Tabereaux, R. Benza, and B. R. Korf Genetic Testing in Cardiovascular Disease J. Am. Coll. Cardiol., August 21, 2007; 50(8): 727 - 737. [Abstract] [Full Text] [PDF]

				M. Hesse, C. S. Kondo, R. B. Clark, L. Su, F. L. Allen, C. T.M. Geary-Joo, S. Kunnathu, D. L. Severson, A. Nygren, W. R. Giles, et al. Dilated cardiomyopathy is associated with reduced expression of the cardiac sodium channel Scn5a Cardiovasc Res, August 1, 2007; 75(3): 498 - 509. [Abstract] [Full Text] [PDF]

				R. K. Riezebos, K. de Man, M. S. Patterson, and G. S. de Ruiter A bridge to Brugada Europace, June 1, 2007; 9(6): 398 - 400. [Abstract] [Full Text] [PDF]

				G. Frigo, A. Rampazzo, B. Bauce, K. Pilichou, G. Beffagna, G. A. Danieli, A. Nava, and B. Martini Homozygous SCN5A mutation in Brugada syndrome with monomorphic ventricular tachycardia and structural heart abnormalities Europace, June 1, 2007; 9(6): 391 - 397. [Abstract] [Full Text] [PDF]

				M. M. Scheinman and E. Keung The Year in Clinical Cardiac Electrophysiology J. Am. Coll. Cardiol., May 22, 2007; 49(20): 2061 - 2069. [Full Text] [PDF]

				K. S. Stokoe, R. Balasubramaniam, C. A. Goddard, W. H. Colledge, A. A. Grace, and C. L.-H. Huang Effects of flecainide and quinidine on arrhythmogenic properties of Scn5a+/ murine hearts modelling the Brugada syndrome J. Physiol., May 15, 2007; 581(1): 255 - 275. [Abstract] [Full Text] [PDF]

				E R Behr, A Casey, M Sheppard, M Wright, T J Bowker, M J Davies, W J McKenna, and D A Wood Sudden arrhythmic death syndrome: a national survey of sudden unexplained cardiac death Heart, May 1, 2007; 93(5): 601 - 605. [Abstract] [Full Text] [PDF]

				V. Probst, I. Denjoy, P. G. Meregalli, J.-C. Amirault, F. Sacher, J. Mansourati, D. Babuty, E. Villain, J. Victor, J.-J. Schott, et al. Clinical Aspects and Prognosis of Brugada Syndrome in Children Circulation, April 17, 2007; 115(15): 2042 - 2048. [Abstract] [Full Text] [PDF]

				M. A. Babaee Bigi, A. Aslani, and S. Shahrzad Prevalence of Brugada sign in patients presenting with palpitation in southern Iran Europace, April 1, 2007; 9(4): 252 - 255. [Abstract] [Full Text] [PDF]

				S. Basavarajaiah, A. Shah, and S. Sharma Sudden cardiac death in young athletes Heart, March 1, 2007; 93(3): 287 - 289. [Abstract] [Full Text] [PDF]

				H. D Esperer, O. Hoos, and K. Hottenrott Syncope due to Brugada syndrome in a young athlete Br. J. Sports Med., March 1, 2007; 41(3): 180 - 181. [Abstract] [Full Text] [PDF]

				M. J. Junttila, M.J. P. Raatikainen, J. S. Perkiomaki, K. Hong, R. Brugada, and H. V. Huikuri Familial clustering of lone atrial fibrillation in patients with saddleback-type ST-segment elevation in right precordial leads Eur. Heart J., February 2, 2007; 28(4): 463 - 468. [Abstract] [Full Text] [PDF]

				A. Sarkozy, T. Boussy, G. Kourgiannides, G.-B. Chierchia, S. Richter, T. De Potter, P. Geelen, F. Wellens, M. Dingena Spreeuwenberg, and P. Brugada Long-term follow-up of primary prophylactic implantable cardioverter-defibrillator therapy in Brugada syndrome Eur. Heart J., February 1, 2007; 28(3): 334 - 344. [Abstract] [Full Text] [PDF]

				M Unlu, F Bengi, B Amasyali, and S Kose Brugada-like electrocardiographic changes induced by fever Emerg. Med. J., January 1, 2007; 24(1): e4 - e4. [Abstract] [Full Text] [PDF]

				R. Coronel, G. Berecki, and T. Opthof Why the Brugada syndrome is not yet a disease: Syndromes, diseases, and genetic causality Cardiovasc Res, December 1, 2006; 72(3): 361 - 363. [Full Text] [PDF]

				F. Sacher, V. Probst, Y. Iesaka, P. Jacon, J. Laborderie, F. Mizon-Gerard, P. Mabo, S. Reuter, D. Lamaison, Y. Takahashi, et al. Outcome After Implantation of a Cardioverter-Defibrillator in Patients With Brugada Syndrome: A Multicenter Study Circulation, November 28, 2006; 114(22): 2317 - 2324. [Abstract] [Full Text] [PDF]

				J. M. Cordeiro, H. Barajas-Martinez, K. Hong, E. Burashnikov, R. Pfeiffer, A.-M. Orsino, Y. S. Wu, D. Hu, J. Brugada, P. Brugada, et al. Compound Heterozygous Mutations P336L and I1660V in the Human Cardiac Sodium Channel Associated With the Brugada Syndrome Circulation, November 7, 2006; 114(19): 2026 - 2033. [Abstract] [Full Text] [PDF]

				M. Dubik Screening for Long QT Syndrome AAP Grand Rounds, November 1, 2006; 16(5): 49 - 50. [Full Text] [PDF]

				C. Veltmann, R. Schimpf, C. Echternach, L. Eckardt, J. Kuschyk, F. Streitner, S. Spehl, M. Borggrefe, and C. Wolpert A prospective study on spontaneous fluctuations between diagnostic and non-diagnostic ECGs in Brugada syndrome: implications for correct phenotyping and risk stratification Eur. Heart J., November 1, 2006; 27(21): 2544 - 2552. [Abstract] [Full Text] [PDF]

				Developed in Collaboration With the European Heart, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) J. Am. Coll. Cardiol., September 5, 2006; 48(5): 1064 - 1108. [Full Text] [PDF]

				Developed in Collaboration With the European Heart, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) J. Am. Coll. Cardiol., September 5, 2006; 48(5): e247 - e346. [Full Text] [PDF]

				D. P. Zipes, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Eur. Heart J., September 1, 2006; 27(17): 2099 - 2140. [Full Text] [PDF]

				Writing Committee Members, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Europace, September 1, 2006; 8(9): 746 - 837. [Full Text] [PDF]

				S. Poelzing, C. Forleo, M. Samodell, L. Dudash, S. Sorrentino, M. Anaclerio, R. Troccoli, M. Iacoviello, R. Romito, P. Guida, et al. SCN5A Polymorphism Restores Trafficking of a Brugada Syndrome Mutation on a Separate Gene Circulation, August 1, 2006; 114(5): 368 - 376. [Abstract] [Full Text] [PDF]

				A. Watanabe, K. Fukushima Kusano, H. Morita, D. Miura, W. Sumida, S. Hiramatsu, K. Banba, N. Nishii, S. Nagase, K. Nakamura, et al. Low-dose isoproterenol for repetitive ventricular arrhythmia in patients with Brugada syndrome Eur. Heart J., July 1, 2006; 27(13): 1579 - 1583. [Abstract] [Full Text] [PDF]

				C. Wren Screening children with a family history of sudden cardiac death. Heart, July 1, 2006; 92(7): 1001 - 1006. [Full Text] [PDF]

				R. Teijeiro, H. A. Garro, R. S. Acunzo, E. Albino, and P. A. Chiale Recording of High V1-V3 Precordial Leads May Be Essential to the Diagnosis of Brugada Syndrome During the Ajmaline Test Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2006; 11(2): 153 - 155. [Abstract] [PDF]

				A. P. Hall and J. A. Henry Acute toxic effects of 'Ecstasy' (MDMA) and related compounds: overview of pathophysiology and clinical management Br. J. Anaesth., June 1, 2006; 96(6): 678 - 685. [Abstract] [Full Text] [PDF]

D. I. Keller, H. Huang, J. Zhao, R. Frank, V. Suarez, E. Delacretaz, M. Brink, S. Osswald, N. Schwick, and M. Chahine A novel SCN5A mutation, F1344S, identified in a patient with Brugada syndrome and fever-induced ventricular fibrillation Cardiovasc Res, June 1, 2006; 70(3): 521 - 529.